162 related articles for article (PubMed ID: 30082428)
1. Carboxylic Acid Derivatives of Amlexanox Display Enhanced Potency toward TBK1 and IKK
Beyett TS; Gan X; Reilly SM; Chang L; Gomez AV; Saltiel AR; Showalter HD; Tesmer JJG
Mol Pharmacol; 2018 Oct; 94(4):1210-1219. PubMed ID: 30082428
[TBL] [Abstract][Full Text] [Related]
2. Design, synthesis, and biological activity of substituted 2-amino-5-oxo-5H-chromeno[2,3-b]pyridine-3-carboxylic acid derivatives as inhibitors of the inflammatory kinases TBK1 and IKKε for the treatment of obesity.
Beyett TS; Gan X; Reilly SM; Gomez AV; Chang L; Tesmer JJG; Saltiel AR; Showalter HD
Bioorg Med Chem; 2018 Nov; 26(20):5443-5461. PubMed ID: 30270002
[TBL] [Abstract][Full Text] [Related]
3. Inflammation produces catecholamine resistance in obesity via activation of PDE3B by the protein kinases IKKε and TBK1.
Mowers J; Uhm M; Reilly SM; Simon J; Leto D; Chiang SH; Chang L; Saltiel AR
Elife; 2013 Dec; 2():e01119. PubMed ID: 24368730
[TBL] [Abstract][Full Text] [Related]
4. The Specific IKKε/TBK1 Inhibitor Amlexanox Suppresses Human Melanoma by the Inhibition of Autophagy, NF-κB and MAP Kinase Pathways.
Möller M; Wasel J; Schmetzer J; Weiß U; Meissner M; Schiffmann S; Weigert A; Möser CV; Niederberger E
Int J Mol Sci; 2020 Jul; 21(13):. PubMed ID: 32630674
[TBL] [Abstract][Full Text] [Related]
5. Dual TBK1/IKKε inhibitor amlexanox mitigates palmitic acid-induced hepatotoxicity and lipoapoptosis in vitro.
Zhou Z; Qi J; Lim CW; Kim JW; Kim B
Toxicology; 2020 Nov; 444():152579. PubMed ID: 32905826
[TBL] [Abstract][Full Text] [Related]
6. FGF21 is required for the metabolic benefits of IKKε/TBK1 inhibition.
Reilly SM; Abu-Odeh M; Ameka M; DeLuca JH; Naber MC; Dadpey B; Ebadat N; Gomez AV; Peng X; Poirier B; Walk E; Potthoff MJ; Saltiel AR
J Clin Invest; 2021 May; 131(10):. PubMed ID: 33822771
[TBL] [Abstract][Full Text] [Related]
7. Amlexanox reversed non-alcoholic fatty liver disease through IKKε inhibition of hepatic stellate cell.
He Q; Xia X; Yao K; Zeng J; Wang W; Wu Q; Tang R; Zou X
Life Sci; 2019 Dec; 239():117010. PubMed ID: 31672578
[TBL] [Abstract][Full Text] [Related]
8. Dual TBK1/IKKɛ inhibitor amlexanox attenuates the severity of hepatotoxin-induced liver fibrosis and biliary fibrosis in mice.
Zhou Z; Qi J; Zhao J; Lim CW; Kim JW; Kim B
J Cell Mol Med; 2020 Jan; 24(2):1383-1398. PubMed ID: 31821710
[TBL] [Abstract][Full Text] [Related]
9. Loss of Tbk1 kinase activity protects mice from diet-induced metabolic dysfunction.
Cruz VH; Arner EN; Wynne KW; Scherer PE; Brekken RA
Mol Metab; 2018 Oct; 16():139-149. PubMed ID: 29935921
[TBL] [Abstract][Full Text] [Related]
10. The TBK1/IKKε inhibitor amlexanox improves dyslipidemia and prevents atherosclerosis.
Zhao P; Sun X; Liao Z; Yu H; Li D; Shen Z; Glass CK; Witztum JL; Saltiel AR
JCI Insight; 2022 Sep; 7(17):. PubMed ID: 35917178
[TBL] [Abstract][Full Text] [Related]
11. Inhibition of IKKɛ and TBK1 Improves Glucose Control in a Subset of Patients with Type 2 Diabetes.
Oral EA; Reilly SM; Gomez AV; Meral R; Butz L; Ajluni N; Chenevert TL; Korytnaya E; Neidert AH; Hench R; Rus D; Horowitz JF; Poirier B; Zhao P; Lehmann K; Jain M; Yu R; Liddle C; Ahmadian M; Downes M; Evans RM; Saltiel AR
Cell Metab; 2017 Jul; 26(1):157-170.e7. PubMed ID: 28683283
[TBL] [Abstract][Full Text] [Related]
12. Pharmacological inhibition of the IKKε/TBK-1 axis potentiates the anti-tumour and anti-metastatic effects of Docetaxel in mouse models of breast cancer.
Bishop RT; Marino S; de Ridder D; Allen RJ; Lefley DV; Sims AH; Wang N; Ottewell PD; Idris AI
Cancer Lett; 2019 May; 450():76-87. PubMed ID: 30790681
[TBL] [Abstract][Full Text] [Related]
13. Amlexanox attenuates LPS-induced neuroinflammatory responses in microglial cells via inhibition of NF-κB and STAT3 signaling pathways.
Phan Van T; Huyen Ton Nu Bao T; Leya M; Zhou Z; Jeong H; Lim CW; Kim B
Sci Rep; 2024 Feb; 14(1):2744. PubMed ID: 38302598
[TBL] [Abstract][Full Text] [Related]
14. An inhibitor of the protein kinases TBK1 and IKK-ɛ improves obesity-related metabolic dysfunctions in mice.
Reilly SM; Chiang SH; Decker SJ; Chang L; Uhm M; Larsen MJ; Rubin JR; Mowers J; White NM; Hochberg I; Downes M; Yu RT; Liddle C; Evans RM; Oh D; Li P; Olefsky JM; Saltiel AR
Nat Med; 2013 Mar; 19(3):313-21. PubMed ID: 23396211
[TBL] [Abstract][Full Text] [Related]
15. Discovery of azabenzimidazole derivatives as potent, selective inhibitors of TBK1/IKKε kinases.
Wang T; Block MA; Cowen S; Davies AM; Devereaux E; Gingipalli L; Johannes J; Larsen NA; Su Q; Tucker JA; Whitston D; Wu J; Zhang HJ; Zinda M; Chuaqui C
Bioorg Med Chem Lett; 2012 Mar; 22(5):2063-9. PubMed ID: 22305584
[TBL] [Abstract][Full Text] [Related]
16. IL-17 axis accelerates the inflammatory progression of obese in mice via TBK1 and IKBKE pathway.
Lee SH; Jhun J; Byun JK; Kim EK; Jung K; Lee JE; Choi JY; Park SH; Cho ML
Immunol Lett; 2017 Apr; 184():67-75. PubMed ID: 28237848
[TBL] [Abstract][Full Text] [Related]
17. Aphthous ulcer drug inhibits prostate tumor metastasis by targeting IKKɛ/TBK1/NF-κB signaling.
Cheng C; Ji Z; Sheng Y; Wang J; Sun Y; Zhao H; Li X; Wang X; He Y; Yao J; Wang L; Zhang C; Guo Y; Zhang J; Gao WQ; Zhu HH
Theranostics; 2018; 8(17):4633-4648. PubMed ID: 30279728
[TBL] [Abstract][Full Text] [Related]
18. Macrophages induce malignant traits in mammary epithelium via IKKε/TBK1 kinases and the serine biosynthesis pathway.
Wilcz-Villega E; Carter E; Ironside A; Xu R; Mataloni I; Holdsworth J; Jones W; Moreno Béjar R; Uhlik L; Bentham RB; Godinho SA; Dalli J; Grose R; Szabadkai G; Jones L; Hodivala-Dilke K; Bianchi K
EMBO Mol Med; 2020 Feb; 12(2):e10491. PubMed ID: 31930708
[TBL] [Abstract][Full Text] [Related]
19. Discovery of BAY-985, a Highly Selective TBK1/IKKε Inhibitor.
Lefranc J; Schulze VK; Hillig RC; Briem H; Prinz F; Mengel A; Heinrich T; Balint J; Rengachari S; Irlbacher H; Stöckigt D; Bömer U; Bader B; Gradl SN; Nising CF; von Nussbaum F; Mumberg D; Panne D; Wengner AM
J Med Chem; 2020 Jan; 63(2):601-612. PubMed ID: 31859507
[TBL] [Abstract][Full Text] [Related]
20. Chrysin modulates protein kinase IKKε/TBK1, insulin sensitivity and hepatic fatty infiltration in diet-induced obese mice.
Amir Siddiqui M; Badruddeen ; Akhtar J; Uddin S; Chandrashekharan SM; Ahmad M; Khan MI; Khalid M
Drug Dev Res; 2022 Feb; 83(1):194-207. PubMed ID: 34350600
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]